Table 3.
Final regression model.
| Variable | B | S.E. | Wald | df | Sig. | Exp(B) | 95% CI for Exp(B) | |
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Age of the patient | −0.03 | 0.01 | 13.70 | 1.00 | 0.00 | 0.97 | 0.96 | 0.99 |
| Positive family history | 0.31 | 0.17 | 3.28 | 1.00 | 0.07 | 1.37 | 0.98 | 1.91 |
| Pet allergy | 0.62 | 0.25 | 6.23 | 1.00 | 0.01 | 1.85 | 1.14 | 3.01 |
| Frequency of bronchodilator use in the past week (ACQ6) | 0.28 | 0.12 | 5.69 | 1.00 | 0.02 | 1.32 | 1.05 | 1.65 |
| Reversibility in % | 0.04 | 0.02 | 2.84 | 1.00 | 0.09 | 1.04 | 0.99 | 1.08 |
| FEV1 pre in % | −0.02 | 0.01 | 4.66 | 1.00 | 0.03 | 0.99 | 0.97 | 1.00 |
| FEV1/FVC post in % | −0.07 | 0.02 | 19.80 | 1.00 | 0.00 | 0.93 | 0.91 | 0.96 |
| Constant | 8.16 | 1.43 | 32.34 | 1.00 | 0.00 | 3481.36 | ||
ACQ Asthma Control Questionnaire, B beta, CI confidence interval, df degrees of freedom, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, S.E. standard error, sig. significance.